Avance Clinical Client Immunic, Inc. Announced Dosing of First Healthy Volunteer in Phase 1 Clinical Program of IMU-856, Targeting Restoration of Intestinal Barrier Function
Adelaide, AUS, Sep 4, 2020 – (ACN Newswire) – The leading Australian CRO for biotechs…
EmailPal Launches Cold Email Infrastructure Platform With Pre-Warmed Email Inboxes, Built-In Deliverability Management, and a Full API and MCP Server for Outbound Teams
NeuroGuard+ Announces Publication of Final Study Showing Reduced Head Acceleration During Repetitive Soccer Heading
Agereh Technologies Announces Board Appointment